ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98 | -100.0% | 100 | -98.7% | 0.00% | -100.0% |
| Q4 2019 | $470,000 | +62.6% | 7,876 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $289,000 | -23.3% | 7,876 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $377,000 | -66.0% | 8,111 | -70.6% | 0.00% | -75.0% |
| Q1 2019 | $1,108,000 | +206.9% | 27,604 | +251.7% | 0.00% | +300.0% |
| Q4 2018 | $361,000 | +7.4% | 7,849 | +3.8% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +60.8% | 7,562 | +42.0% | 0.00% | 0.0% |
| Q2 2018 | $209,000 | -81.3% | 5,326 | -65.5% | 0.00% | -80.0% |
| Q1 2018 | $1,116,000 | +255.4% | 15,436 | +223.2% | 0.01% | +400.0% |
| Q4 2017 | $314,000 | +119.6% | 4,776 | +54.1% | 0.00% | 0.0% |
| Q2 2017 | $143,000 | +31.2% | 3,100 | -6.1% | 0.00% | 0.0% |
| Q1 2017 | $109,000 | – | 3,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |